Ezetimibe + atorvastatin sandoz

Package leaflet: Information for the patient

Ezetimibe + Atorvastatin Sandoz, 10 mg + 10 mg, film-coated tablets
Ezetimibe + Atorvastatin Sandoz, 10 mg + 20 mg, film-coated tablets
Ezetimibe + Atorvastatin Sandoz, 10 mg + 40 mg, film-coated tablets
Ezetimibe + Atorvastatin Sandoz, 10 mg + 80 mg, film-coated tablets
Ezetimibum + Atorvastatinum
Please read this leaflet carefully before taking this medicine, as it contains
important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any further questions, please ask your doctor or pharmacist.
• This medicine has been prescribed for a specific individual. Do not pass it on to others. It may harm other people, even if their symptoms are the same.
• If you experience any adverse reactions, including any not listed in this leaflet, tell your doctor or pharmacist. See section 4.

Table of contents

1. What Ezetimibe + Atorvastatin Sandoz is and what it is used for
2. Important information before taking Ezetimibe + Atorvastatin Sandoz
3. How to take Ezetimibe + Atorvastatin Sandoz
4. Possible side effects
5. How to store Ezetimibe + Atorvastatin Sandoz
6. Contents of the pack and other information

1. What Ezetimibe + Atorvastatin Sandoz is and what it is used for

Ezetimibe + Atorvastatin Sandoz is a medicine that lowers high levels of cholesterol. Ezetimibe + Atorvastatin Sandoz contains two active substances: ezetimibe and atorvastatin.
Ezetimibe + Atorvastatin Sandoz is used in adults to lower levels of total cholesterol, "bad" cholesterol (LDL cholesterol), and fat substances called triglycerides in the blood. Additionally, Ezetimibe + Atorvastatin Sandoz increases levels of "good" cholesterol (HDL cholesterol).
Ezetimibe + Atorvastatin Sandoz reduces cholesterol levels in two ways: by decreasing cholesterol absorption in the gastrointestinal tract and by reducing cholesterol production in the body.
Cholesterol is one of several fatty substances present in the blood. Total cholesterol consists mainly of LDL and HDL cholesterol.
LDL cholesterol is often called "bad" cholesterol because it can deposit in the walls of arteries and form atherosclerotic plaques. Over time, these plaques may narrow the arteries. This narrowing can slow down or block blood flow to vital organs such as the heart and brain. Blocked blood flow may lead to heart attack or stroke.
HDL cholesterol is often called "good" cholesterol because it helps prevent "bad" cholesterol from depositing in artery walls and thus helps protect against heart disease.
Triglycerides are other fats present in the blood that may increase the risk of heart disease.
Ezetimibe + Atorvastatin Sandoz is used in patients whose cholesterol levels cannot be controlled by diet alone. While taking this medicine, you should follow a cholesterol-lowering diet.
Ezetimibe + Atorvastatin Sandoz is used as an addition to a cholesterol-lowering diet in the following cases:

• High cholesterol levels in the blood (primary hypercholesterolemia [heterozygous familial or non-familial]) or high levels of fatty substances in the blood (mixed hyperlipidemia), when adequate control has not been achieved with statin monotherapy, or when statins and ezetimibe have previously been used as separate tablets.
• A hereditary condition (homozygous familial hypercholesterolemia) that causes high cholesterol levels in the blood. Other treatment methods may also be used.
• Heart disease. Ezetimibe + Atorvastatin Sandoz reduces the risk of heart attack, stroke, procedures to improve blood flow to the heart, or hospitalization due to chest pain.

Ezetimibe + Atorvastatin Sandoz does not affect body weight reduction.

2. Important information before using Ezetimibe + Atorvastatin Sandoz

When not to use Ezetimibe + Atorvastatin Sandoz

• if the patient is allergic to ezetimibe, atorvastatin, or any of the other ingredients of this medicine (listed in section 6);
• if the patient currently has or has previously had liver disease;
• if the patient has unexplained abnormal results of liver function blood tests;
• if the patient is of childbearing potential and is not using effective methods of contraception;
• if the patient is pregnant, trying to become pregnant, or breastfeeding;
• if the patient is taking glecaprevir with pibrentasvir for the treatment of hepatitis C virus infection.

Warnings and precautions
Before starting treatment with Ezetimibe + Atorvastatin Sandoz, discuss with your doctor or pharmacist if:

• the patient has previously had a haemorrhagic stroke or has small fluid-filled cysts in the brain as a result of previous strokes;
• the patient has kidney problems;
• the patient has hypothyroidism;
• the patient has recurrent or unexplained muscle pain, or a history of muscle disorders in the past or in the family;
• the patient has experienced muscle-related symptoms during previous treatment with other lipid-lowering medicines (e.g. other "statins" or "fibrates");
• the patient regularly consumes large amounts of alcohol;
• the patient has previously had liver disease;
• the patient is over 70 years of age;
• the patient has previously been diagnosed with intolerance to certain sugars, the patient should contact the doctor before taking this medicine;
• the patient currently has or has had myasthenia (a disease causing generalised muscle weakness, including in some cases the muscles used for breathing) or ocular myasthenia (a disease causing weakness of the eye muscles), because statins may occasionally worsen the condition or lead to the development of myasthenia (see section 4);
• the patient is currently taking or has taken within the last 7 days fusidic acid (a medicine used to treat bacterial infections) orally or by injection. The combination of fusidic acid and Ezetimibe + Atorvastatin Sandoz may lead to serious muscle problems (rhabdomyolysis).

Contact your doctor immediately if you experience unexplained muscle pain,
tenderness or weakness while taking Ezetimibe + Atorvastatin Sandoz, as in rare cases
muscle disorders may be severe, including muscle breakdown, which may cause kidney damage.
It is known that atorvastatin may cause muscle disorders. Cases of muscle disorders have also
been reported during treatment with ezetimibe. Inform your doctor or pharmacist if muscle
weakness persists. Additional tests and possibly additional treatment may be necessary to
diagnose and manage this condition.
Before taking Ezetimibe + Atorvastatin Sandoz, consult your doctor or pharmacist:

• if the patient has severe respiratory insufficiency.

If any of the above conditions are present (or suspected), consult your doctor or pharmacist, as the doctor may need to perform blood tests before starting treatment with Ezetimibe + Atorvastatin Sandoz and possibly during treatment to assess the risk of muscle-related adverse effects. It is known that the risk of muscle-related adverse effects, such as rhabdomyolysis, may be increased by certain concomitant medicines (see section 2, "Ezetimibe + Atorvastatin Sandoz and other medicines").
During treatment with this medicine, your doctor will closely monitor you for diabetes or risk of developing diabetes. You are at increased risk of developing diabetes if you have high blood sugar and lipid levels, are overweight, and have hypertension.
Inform your doctor about all medical conditions, including allergies.
Avoid concomitant use of Ezetimibe + Atorvastatin Sandoz and fibrates (medicines that lower cholesterol), as this combination has not been studied.

Children
Ezetimibe + Atorvastatin Sandoz is not recommended for use in children and adolescents.

Ezetimibe + Atorvastatin Sandoz and other medicines
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, including those available without a prescription, as well as any medicines you plan to take.
There are medicines that may alter the effect of Ezetimibe + Atorvastatin Sandoz or whose effects may be altered by Ezetimibe + Atorvastatin Sandoz (see section 3). This type of interaction may reduce the effectiveness of one or both medicines. It may also increase the risk or severity of adverse effects, including the occurrence of a serious muscle-damaging condition known as "rhabdomyolysis", described in section 4:

• cyclosporine (a medicine often used in organ transplant patients),
• erythromycin, clarithromycin, telithromycin, fusidic acid**, rifampicin (medicines used to treat bacterial infections),
• ketoconazole, itraconazole, voriconazole, fluconazole, posaconazole (medicines used to treat fungal infections),
• gemfibrozil, other fibrates, nicotinic acid, derivatives, colestipol, cholestyramine (medicines used to regulate lipid levels),
• certain calcium channel blockers used for angina or hypertension, e.g. amlodipine, diltiazem,
• digoxin, verapamil, amiodarone (medicines that regulate heart rhythm),
• medicines used to treat HIV infection, e.g. ritonavir, lopinavir, atazanavir, indinavir, darunavir, the combination of tipranavir/ritonavir, etc. (medicines used in AIDS);
• certain medicines used to treat hepatitis C virus infection, e.g. telaprevir, boceprevir, and the fixed-dose combination of elbasvir with grazoprevir,
• daptomycin (a medicine used to treat complicated skin and soft tissue infections and bacteremia).

**If oral fusidic acid is required to treat a bacterial infection,
treatment with Ezetimibe + Atorvastatin Sandoz should be temporarily discontinued. Your doctor will advise when it is safe to resume taking Ezetimibe + Atorvastatin Sandoz. Concomitant use of Ezetimibe + Atorvastatin Sandoz and fusidic acid may rarely lead to muscle weakness, tenderness or pain (rhabdomyolysis). More information on rhabdomyolysis is provided in section 4.

• Other medicines known to interact with Ezetimibe + Atorvastatin Sandoz:
  o oral contraceptives (used for birth control),
  o stiripentol (an anticonvulsant used to treat epilepsy),
  o cimetidine (used for heartburn and peptic ulcer disease),
  o phenazone (a painkiller),
  o antacids (medicines for indigestion containing aluminium or magnesium compounds),
  o warfarin, phenprocoumon, acenocoumarol or fluindione (medicines used to prevent blood clots),
  o colchicine (used to treat gout),
  o St John’s wort (a herbal remedy used to treat depression).

Ezetimibe + Atorvastatin Sandoz with food and alcohol
Instructions for taking Ezetimibe + Atorvastatin Sandoz are provided in section 3. Please pay attention to the following:

Grapefruit juice
Do not consume more than one or two small glasses of grapefruit juice per day, as larger amounts may alter the effect of Ezetimibe + Atorvastatin Sandoz.
Alcohol
Avoid excessive alcohol consumption while taking this medicine. Further information is available in section 2, "Warnings and precautions".

Pregnancy and breastfeeding
Women who are pregnant, trying to become pregnant, or who suspect they may be pregnant should not take Ezetimibe + Atorvastatin Sandoz. Do not take Ezetimibe + Atorvastatin Sandoz if there is a possibility of becoming pregnant and the patient is not using effective contraception. If pregnancy occurs while taking Ezetimibe + Atorvastatin Sandoz, stop taking the medicine immediately and inform your doctor.
Do not take Ezetimibe + Atorvastatin Sandoz during breastfeeding.
The safety of Ezetimibe + Atorvastatin Sandoz during pregnancy and breastfeeding has not been established.
Consult your doctor or pharmacist before taking this medicine.

Driving and operating machinery
Ezetimibe + Atorvastatin Sandoz is not expected to affect the ability to drive or operate machinery. However, be aware that dizziness may occur in some patients after taking Ezetimibe + Atorvastatin Sandoz.

Ezetimibe + Atorvastatin Sandoz contains lactose
Ezetimibe + Atorvastatin Sandoz tablets contain a sugar called lactose. If the patient has previously been diagnosed with intolerance to certain sugars, the patient should contact the doctor before taking this medicine.

Ezetimibe + Atorvastatin Sandoz contains sodium
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, meaning the medicine is considered "sodium-free".

3. How to take Ezetimibe + Atorvastatin Sandoz
This medicine should always be taken exactly as prescribed by your doctor. Your doctor will prescribe the appropriate strength of tablet based on your current treatment and individual risk. If in doubt, consult your doctor or pharmacist.

• Before starting Ezetimibe + Atorvastatin Sandoz, a cholesterol-lowering diet should be initiated.
• This diet should be continued during treatment with Ezetimibe + Atorvastatin Sandoz.

Recommended dose
The recommended dose is one tablet of Ezetimibe + Atorvastatin Sandoz taken orally once daily.

When to take the medicine
Ezetimibe + Atorvastatin Sandoz can be taken at any time of day, with or without food.
If your doctor has prescribed Ezetimibe + Atorvastatin Sandoz together with cholestyramine or another bile acid-binding medicine (intended to lower cholesterol levels), Ezetimibe + Atorvastatin Sandoz should be taken at least 2 hours before or 4 hours after the bile acid-binding medicine.

Taking more than the recommended dose of Ezetimibe + Atorvastatin Sandoz
Seek advice from your doctor or pharmacist.

Missing a dose of Ezetimibe + Atorvastatin Sandoz
Do not take a double dose. Take the usual dose of Ezetimibe + Atorvastatin Sandoz at the normal time the next day.

If you have any further questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse reactions

Like all medicines, this medicine can cause adverse reactions, although not everybody gets them.
If any of the following serious adverse reactions or symptoms occur, stop taking the medicine and
contact a doctor immediately or go to the nearest hospital emergency department.

• severe allergic reactions causing swelling of the face, tongue and throat, which may significantly impair breathing,
• severe illness with extensive skin peeling and swelling, formation of blisters on the skin, in the mouth, eyes and genital organs, and fever; skin rash with

pink-red spots, particularly on the palms and soles, which may
lead to blister formation,

• muscle weakness, tenderness, pain or tearing, or red-brown discoloration of urine, especially if accompanied by malaise or fever, which may be due to muscle breakdown that can be life-threatening and lead to kidney problems,
• lupus-like syndrome (including rash, joint disorders and effects on blood cells).

If unexpected or unusual bleeding or bruising occurs, contact a doctor immediately, as these may be symptoms of liver disorders.
The following common adverse reactions have been reported (may affect up to 1 in 10 people):

• diarrhoea,
• muscle pain.

The following uncommon adverse reactions have been reported (may affect up to 1 in 100 people):

• influenza-like illness,
• depression, difficulty falling asleep, sleep disturbances,
• dizziness, headache, tingling sensation,
• slow heart rate,
• hot flushes,
• shortness of breath,
• abdominal pain, bloating, constipation, indigestion, passing wind, frequent defecation, gastric inflammation, nausea, gastric discomfort, gastrointestinal discomfort;
• acne, urticaria,
• joint pain, back pain, leg cramps, fatigue, muscle cramps or weakness, pain in arms and legs,
• unusual weakness, feeling of tiredness or malaise, swelling, especially of the ankles,
• increased levels in blood laboratory tests related to liver or muscle function (CK),
• weight gain.

Additionally, the following adverse reactions have been reported in patients taking Ezetimibe + Atorvastatin Sandoz, ezetimibe or atorvastatin tablets:

• allergic reactions, including swelling of the face, lips, tongue and/or throat, which may cause difficulty in breathing or swallowing (requiring immediate treatment),
• red rash, sometimes with target-shaped lesions,
• liver problems,
• cough,
• heartburn,
• reduced appetite; loss of appetite,
• high blood pressure,
• skin rash and itching; allergic reactions, including rash and urticaria,
• tendon damage,
• gallstones or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting),
• pancreatitis, often with severe abdominal pain,
• decreased number of blood cells, which may lead to bruising/bleeding (thrombocytopenia),
• nasal inflammation; nosebleeds,
• neck pain; pain; chest pain; sore throat,
• increased or decreased blood glucose levels (in patients with diabetes, careful monitoring of blood glucose levels should be continued),
• nightmares,
• numbness or tingling in fingers of hands and feet,
• reduced sensation to pain or touch,
• altered taste sensation; dry mouth,
• memory loss,
• ringing in the ears and/or head; hearing loss,
• vomiting,
• belching,
• hair loss,
• elevated body temperature,
• positive urine test for white blood cells,
• blurred vision; visual disturbances,
• gynaecomastia (enlargement of breasts in males).

Possible adverse reactions reported with some statins:

• sexual dysfunction,
• depression,
• breathing problems, including persistent cough and/or shortness of breath or fever,
• diabetes. This is more likely in patients with high levels of blood sugar and fats, overweight and high blood pressure. Your doctor will monitor your condition during treatment with this medicine,
• muscle pain, tenderness or persistent muscle weakness, especially if accompanied by malaise or high fever, which may not resolve after discontinuation of Ezetimibe + Atorvastatin Sandoz (frequency unknown).
• Myasthenia gravis (a disease causing generalised muscle weakness, including in some cases muscles used for breathing).
• Ocular myasthenia (a disease causing weakness of eye muscles).

Contact a doctor if the patient develops weakness in arms or legs that worsens with activity, double vision or drooping eyelids, difficulty swallowing or shortness of breath.
Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform a doctor or pharmacist. Adverse reactions can be reported directly to the Department of Monitoring Adverse Reactions to Medicinal Products at the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: + 48 22 49-21-301, Fax: + 48 22 49-21-309, Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the marketing authorisation holder.
Reporting adverse reactions helps provide more information on the safety of the medicine.

5. How to store Ezetimibe + Atorvastatin Sandoz

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the stated month.
This medicinal product does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Ezetimibe + Atorvastatin Sandoz contains
Ezetimibe + Atorvastatin Sandoz 10 mg + 10 mg: each film-coated tablet contains 10 mg of ezetimibe and 10 mg of atorvastatin (as calcium trihydrate salt).
Ezetimibe + Atorvastatin Sandoz 10 mg + 20 mg: each film-coated tablet contains 10 mg of ezetimibe and 20 mg of atorvastatin (as calcium trihydrate salt).
Ezetimibe + Atorvastatin Sandoz 10 mg + 40 mg: each film-coated tablet contains 10 mg of ezetimibe and 40 mg of atorvastatin (as calcium trihydrate salt).
Ezetimibe + Atorvastatin Sandoz 10 mg + 80 mg: each film-coated tablet contains 10 mg of ezetimibe and 80 mg of atorvastatin (as calcium trihydrate salt).

Other ingredients are:
Tablet core:
microcrystalline cellulose 101, mannitol, calcium carbonate, sodium croscarmellose, hydroxypropylcellulose (E 463), polysorbate 80, yellow iron oxide, magnesium stearate, povidone K29/32, sodium lauryl sulfate.

Tablet coating:
Ezetimibe + Atorvastatin Sandoz 10 mg + 10 mg, 10 mg + 20 mg, 10 mg + 40 mg – Opadry White OY-L-28900 consisting of:
lactose monohydrate
hypromellose 2910
titanium dioxide
macrogol 4000

Ezetimibe + Atorvastatin Sandoz 10 mg + 80 mg – DrCoat FCU consisting of:
hypromellose 2910
titanium dioxide
talc
macrogol 400
yellow iron oxide

What Ezetimibe + Atorvastatin Sandoz looks like and contents of the pack
Ezetimibe + Atorvastatin Sandoz 10 mg + 10 mg film-coated tablets: white, round, biconvex film-coated tablets with a diameter of approximately 8.1 mm.
Ezetimibe + Atorvastatin Sandoz 10 mg + 20 mg film-coated tablets: white, oval, biconvex film-coated tablets with dimensions of approximately 11.6 x 7.1 mm.
Ezetimibe + Atorvastatin Sandoz 10 mg + 40 mg film-coated tablets: white, capsule-shaped, biconvex film-coated tablets with dimensions of approximately 16.1 x 6.1 mm.
Ezetimibe + Atorvastatin Sandoz 10 mg + 80 mg film-coated tablets: yellow, elongated, biconvex film-coated tablets with dimensions of 19.1 x 7.6 mm.

Ezetimibe + Atorvastatin Sandoz 10 mg + 10 mg, 10 mg + 20 mg, 10 mg + 40 mg film-coated tablets
Blister packs made of OPA/Aluminium/PVC//Aluminium foil containing 30, 90 and 100 film-coated tablets in a cardboard box.
Single-dose blister packs made of OPA/Aluminium/PVC//Aluminium foil containing 30x1, 90x1 and 100x1 film-coated tablets, in a cardboard box.

Ezetimibe + Atorvastatin Sandoz 10 mg + 80 mg film-coated tablets
Blister packs made of OPA/Aluminium/PVC//Aluminium foil containing 30 tablets, a multipack containing 90 (2 packs of 45) and a multipack containing 100 (2 packs of 50) film-coated tablets in a cardboard box.
Single-dose blister packs made of OPA/Aluminium/PVC//Aluminium foil containing 30 x 1 single dose, a multipack containing 90 x 1 (2 packs of 45 x 1) and a multipack containing 100 x 1 (2 packs of 50 x 1) film-coated tablets in a cardboard box.

Not all pack sizes may be marketed.

Marketing Authorisation Holder
Sandoz Polska Sp. z o.o.
ul. Domaniewska 50C
02-672 Warszawa
tel. 22 209 70 00

Manufacturer
Elpen Pharmaceuticals Co. Inc.
Marathonos Avenue 95
19009 Pikermi
Greece

Lek Pharmaceuticals d.d.
Verovskova Ulica 57
1526 Ljubljana
Slovenia

This medicinal product is authorised in the European Economic Area countries under the following names:
Netherlands Ezetimibe/Atorvastatine Sandoz 10 mg/10 mg, filmomhulde tabletten
Ezetimibe/Atorvastatine Sandoz 10 mg/20 mg, filmomhulde tabletten
Ezetimibe/Atorvastatine Sandoz 10 mg/40 mg, filmomhulde tabletten
Ezetimibe/Atorvastatine Sandoz 10 mg/80 mg, filmomhulde tabletten

Belgium Tymyzato 10 mg/20 mg filmomhulde tabletten
Tymyzato 10 mg/40 mg filmomhulde tabletten
Tymyzato 10 mg/80 mg filmomhulde tabletten

Spain Ezetimiba/Atorvastatina Sandoz Farmacéutica 10 mg/10 mg comprimidos recubiertos con película EFG
Ezetimiba/Atorvastatina Sandoz Farmacéutica 10 mg/20 mg comprimidos recubiertos con película EFG
Ezetimiba/Atorvastatina Sandoz Farmacéutica 10 mg/40 mg comprimidos recubiertos con película EFG
Ezetimiba/Atorvastatina Sandoz Farmacéutica 10 mg/80 mg comprimidos recubiertos con película EFG

France EZETIMIBE/ATORVASTATINE SANDOZ 10 mg/10 mg, comprimé pelliculé
EZETIMIBE/ATORVASTATINE SANDOZ 10 mg/20 mg, comprimé pelliculé
EZETIMIBE/ATORVASTATINE SANDOZ 10 mg/40 mg, comprimé pelliculé
EZETIMIBE/ATORVASTATINE SANDOZ 10 mg/80 mg, comprimé pelliculé

Italy Ezetimibe e Atorvastatina Sandoz

Portugal Atorvastatina + Ezetimiba Sandoz Farmacêutica

Germany Ezetimib/Atorvastatin - 1 A Pharma 10 mg/10 mg Filmtabletten
Ezetimib/Atorvastatin - 1 A Pharma 10 mg/20 mg Filmtabletten
Ezetimib/Atorvastatin - 1 A Pharma 10 mg/40 mg Filmtabletten
Ezetimib/Atorvastatin - 1 A Pharma 10 mg/80 mg Filmtabletten

Greece Ancilleg

Lithuania Ezetimibe/Atorvastatin Sandoz 10 mg/10 mg plėvele dengtos tabletės
Ezetimibe/Atorvastatin Sandoz 10 mg/20 mg plėvele dengtos tabletės
Ezetimibe/Atorvastatin Sandoz 10 mg/40 mg plėvele dengtos tabletės

Croatia Ezetimib/atorvastatin Sandoz 10 mg/10 mg filmom obložene tablete
Ezetimib/atorvastatin Sandoz 10 mg/20 mg filmom obložene tablete
Ezetimib/atorvastatin Sandoz 10 mg/40 mg filmom obložene tablete
Ezetimib/atorvastatin Sandoz 10 mg/80 mg filmom obložene tablete

Poland Ezetimibe + Atorvastatin Sandoz

Hungary Ezetimibe/Atorvastatin 1 A Pharma 10 mg/10 mg filmtabletta
Ezetimibe/Atorvastatin 1 A Pharma 10 mg/20 mg filmtabletta
Ezetimibe/Atorvastatin 1 A Pharma 10 mg/40 mg filmtabletta
Ezetimibe/Atorvastatin 1 A Pharma 10 mg/80 mg filmtabletta

Romania Ezetimib/Atorvastatină Sandoz 10 mg/10 mg comprimate filmate
Ezetimib/Atorvastatină Sandoz 10 mg/20 mg comprimate filmate
Ezetimib/Atorvastatină Sandoz 10 mg/40 mg comprimate filmate
Ezetimib/Atorvastatină Sandoz 10 mg/80 mg comprimate filmate

Slovakia Ezetimib/Atorvastatín Sandoz 10 mg/10 mg
Ezetimib/Atorvastatín Sandoz 10 mg/20 mg
Ezetimib/Atorvastatín Sandoz 10 mg/40 mg
Ezetimib/Atorvastatín Sandoz 10 mg/80 mg